Assessing the risk of ovarian hyperstimulation syndrome in egg donation: Implications for Human embryonic stem cell research

American Journal of Bioethics

Volumn 11, Issue 9, 2011, Pages 22-30

  Ellison, Brooke ^a   Meliker, Jaymie ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Biomedical research; Cloning; Ethics committees; Health policy; Research ethics; Stem cell research

Indexed keywords

CELL NUCLEUS TRANSPLANTATION; DECISION MAKING; ECONOMICS; ETHICS; FEMALE; HEALTH CARE POLICY; HUMAN; INFERTILITY THERAPY; OOCYTE DONATION; OVARY HYPERSTIMULATION; POLICY; RESEARCH ETHICS; REVIEW; STEM CELL RESEARCH; UNITED STATES;

CHOICE BEHAVIOR; ETHICS, RESEARCH; FEMALE; HEALTH POLICY; HUMANS; NUCLEAR TRANSFER TECHNIQUES; OOCYTE DONATION; OVARIAN HYPERSTIMULATION SYNDROME; PUBLIC POLICY; REPRODUCTIVE TECHNIQUES, ASSISTED; STEM CELL RESEARCH; UNITED STATES;

EID: 80052219811     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2011.593683     Document Type: Review

References (34)

1. Ahuja, K. K., E.G. Simons, and R.G. Edwards. 1999. Money, morals, and medical risks: conflicting notions underlying the recruitment of egg donors. Human Reproduction 14: 279-284.
2. Angel, S. 2007. Value of the human egg: An analysis of risk and reward in stem cell research. Berkeley Journal of Gender, Law, And Justice 183-224.
3. Balen, A., and K. Michelmore. 2002. What is polycystic ovary syndrome? Are national views important? Human Reproduction 17: 2219-2227.
4. Beeson, D., and A. Lippman. 2006. Egg harvesting for stem cell research: Medical risks and ethical problems. Reproductive Biomedicine Online 13: 573-579.
5. Berg, T. 2009. Scrambled ethics. National Review Online. Available at: http://www.nationalreview.com/author/217584/latest
6. Bodri, D. 2008. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reproductive BioMedicine Online 17(3): 237-243.
7. Cato, P. C. 2005. Hidden costs of fertility. Remarks given at the St. John's Journal of Legal Commentary February 25, 2005.
8. Delbaere, A., G. Smits, A. DeLeener, S. Costagliola, and G. Vassart. 2005. Understanding ovarian hyperstimulation syndrome. Endocrine 26(3): 285-289.
9. Delvigne, A., M. Dubois, B. Battheu, et al. 1993. The ovarian hyperstimulation syndrome in in vitro fertilization: A Belgian multicentric study. Multiple discriminant analysis for risk prediction. Human Reproduction 5(7): 816-818.
10. Delvigne, A., and S. Rozenberg. 2002. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS). Human Reproduction 8(6): 559-577.
11. Enskog, A., L. Nilsson, and M. Brannstrom. 1999. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for individual fertilization. Fertility and Sterility 71: 808-814.
12. George, K. 2007. What about thewomen? Ethical and policy aspects of egg supply for cloning research. Reproductive Biomedicine Online 15(2): 127-133.
13. Higgs, D. 2008. A new dawn for stem cell therapy. New England Journal of Medicine 358(9): 964-966.
14. Kalfoglou, A., and J. Gittelsohn. 2000. Aqualitative follow-up study of women's experiences with oocyte donation. Human Reproduction 15(4): 798-805.
15. Kenney, N., and M. McGowan. 2008. Looking back: Egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle. Fertility and Sterility 15(2): 1-13.
16. Kim, K., A. Doi, B. Wen, K. Ng, R. Zhao, P. Cahan, J. Kim, M. J. Aryee, H. Ji, L. I. R. Ehrlich, A. Yabuuchi, A. Takeuchi, K.C. Cunniff, H. Hongguang, S. McKinney-Freeman, O. Naveiras, T.J. Yoon, A. Irizarry, N. Jung, J. Seita, J. Hanna, P. Murakami, R. Jaenisch, R. Weissleder, S. H. Orkin, I. Weissman, A. P. Feinberg, and G. Q. Daley. 2010. Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290.
17. Klemetti, R., T. Sevon, M. Gissler, and E. Hemminki. 2005. Complications of IVF and ovulation induction. Human Reproduction 20(12): 3293-3300.
18. NYSTEM. (2009). Statement of the Empire State Stem Cell Board on the compensation of oocyte donors. Available at: http://stemcell.ny.gov/oocytedonation.html
19. Mathur, R., and J. Jenkins,. 2001. Ovarian hyperstimulation syndrome: An endocrinopathy? Current Opinion in Obstetrics and Gynecology 13: 329-333.
20. MacDougall, M. J., S. L. Tan, and H. S. Jacobs. 1992. In vitro fertilization and the ovarian hyperstimulation syndrome. Human Reproduction 7: 597-600.
21. Mertes, H., and G. Pennings. 2007. Oocyte donation for stem cell research. Human Reproduction 22(3): 629-634.
22. Neveu, S., B. Hedon, P. Mares, et al. 1987. IVF and polycystic ovarian syndrome. Human Reproduction 2: 77-80.
23. Norsigian, J. 2005. Egg donation for IVF and stem cell research: Time to weigh the risks to women's health. Different Takes 33.
24. Padilla, S. L., S. Zamaria, T. A. Baramki, and J. E. Garcia. 1990. Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fertility and Sterility 53: 365-367.
25. Papanikolaou, E., H. Tournaye, W. Verpoest, et al. 2005. Early and late ovarian hyperstimulation syndrome: Early pregnancy outcome and profile. Human Reproduction 20(3): 636-641.
26. Pattinson, H. A., M. Hignett, B. C. Dunphy, and J.A. Fleetham. 1994. Outcome of thaw embryo transfer after cryo preservation of all embryos in patients at risk of ovarian hyperstimulation syndrome. Fertility and Sterility 62: 1192-1196.
27. Polo, J. M., S. Liu, M. E. Figueroa, W. Kulalert, S. Eminli, K. Y. Tan, E. Apostolou, M. Stadtfeld, Y. Li, T. Shioda, S. Natesan, A. J. Wagers, A. Melnick, T. Evans, and K. Hochedlinger. 2010. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology 28: 848-855.
28. Rao, R. 2006. Coercion, commercialization, and commodification: The ethics of compensation for egg donors in the stem cell research. Berkeley Technology Law Journal 21(3): 1055-1067.
29. Rizk, B., and M. A. Aboulghar. 1991. Modern management of ovarian hyperstimulation syndrome. Human Reproduction 6: 1082-1087.
30. Roest, J., H. Mous, G. Zeilmaker, and A. Verhoeff. 1996. The incidence of major clinical complications in a Dutch transport IVF programme. Human Reproduction 2(4): 345-353.
31. Smitz, J., M. Camus, and P. Devroey. 1990. Incidence of severe ovarian hyperstimulation syndrome afterGnRH agonist/HMG superovulation for in vitro fertilization. Human Reproduction 5: 933-937.
32. Soderstrom-Anttila, V., T. Foudila, and H. Outi. 1996. Arandomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme. Human Reproduction 11(9): 1864-1870.
33. Tang, T., J. Glanville, N. Orsi, J. Barth, and A. Balen. 2006. Use of metformin for women with PCOS undergoing IVF treatment. Human Reproduction 21(6): 1416-1425.
34. Venn, A., E. Hemminki, L. Watson, F. Bruinsma, and D. Healy. 2001. Mortality in a cohort of IVF patients. Human Reproduction 16(12): 2691-2696.